Cerebral Autoregulation in Alzheimer's Disease. Before and After Treatment with Galantamine: an Open-Label Pilot Study.
Completed
- Conditions
- dementiaAlzheimer's Disease100079631001227210003216
- Registration Number
- NL-OMON32291
- Lead Sponsor
- niversitair Medisch Centrum Sint Radboud
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
Meeting DMS-IV R criteria for dementia
meeting NINCDS-ADRDA criteria for probable AD
clinical dementia rating scale (CDR) 0.5 - 2
Exclusion Criteria
Contra-indication for or unwilling to receive treatment with cholinesterase inhibitors
major cerebrovascular disease (stroke)
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method